Drug interactions
Adalimumab + Canakinumab
Severity: Major
Adalimumab and Canakinumab: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Canakinumab (IL-1 beta blocker) combined with adalimumab (TNF blocker) increases the risk of serious infections, as seen with other combinations of biologic cytokine inhibitors, without proven added benefit.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Adalimumab and Canakinumab interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Adalimumab
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
